IBS Intelligence (IBSi) is the world’s only pure-play Financial Technology focused research, advisory, and fintech news analysis firm, with a 30-year track record and clients globally. We take pride ...

Missing data present a perennial challenge in scientific research, potentially undermining the validity of conclusions if not addressed rigorously. The analysis of missing data encompasses a broad ...

Extracting and analyzing relevant medical information from large-scale databases such as biobanks poses considerable challenges. To exploit such "big data," attempts have focused on large sampling ...

In pet genetics, cancer research, and beyond, Charlie Lieu, MBA ’05, SM ’05, has spent her career harnessing massive data ...

NEW DELHI: As India’s pharmaceutical industry moves towards becoming a 500 billion dollars global powerhouse by 2047, a new report highlighted the growing role of non-animal, science-driven testing ...

The San Francisco start-up claimed that DeepSeek, Moonshot and MiniMax used approximately 24,000 fraudulent accounts to train their own chatbots.

A team of UCSF researchers successfully tested several mainstream AI agents for the ability to analyze big data on women's ...

A University of Hawaiʻi at Mānoa student-led team has developed a new algorithm to help scientists determine direction in complex two-dimensional (2D) data, with potential applications ranging from ...

Is the scientific method really the best approach to learning about the world? A new paper in Collective Intelligence applies the scientific method to itself, finding that some common strategies that ...

As the population ages, China will face an ever-increasing burden from CS. Strategies targeting elder population and high-risk groups should be prioritized in the establishment of management related ...

Introduction Cerebral palsy (CP) is a non-progressive condition involving movement and muscle tone difficulties due to injury to the developing brain. Most cases arise around birth, but a smaller ...

More than 80% of those treated with TREMFYA® were in clinical remission and more than 50% were in endoscopic remission at Week 140 of the QUASAR long-term ...